We hope you and your family remain safe and healthy as we navigate through uncharted waters with the COVID-19 pandemic. We know that you have faced challenges with decisions around the care of your patients, balancing the need for treatment of their cancer with the concerns for their general health. These issues have weighed upon all our minds.
Through these unprecedented times, the ROI has remained steadfast in its mission “to heighten the critical role of radiation therapy in the treatment of cancer through research and education.” The Radiation Oncology Institute is continuing its commitment to fund practice-changing research with the awarding of four new research grants in 2020. The ROI received and reviewed 19 proposals for new research to improve diversity and inclusion in radiation oncology and selected four proposals to fund going forward. You will find more information on these award-winning research teams seeking to reduce disparities and increase health equity in this newsletter.
We would like to call your attention to the first James D. Cox Resident’s Research Award, presented this year to Oluwadamilola Oladeru, MD, from the Harvard Radiation Oncology Program. She will be examining cancer care including radiation treatment in the Federal Bureau of Prisons. This special award was funded through the generosity of Ritsuko Komaki Cox, MD, FASTRO, in memory of her late husband, James D. Cox, MD, FASTRO.
On the education side, the ROI continues to support the ARRO del Regato Webinar Series, which is free for residents. In April, over 100 residents participated in the live eContouring for Head and Neck Cancer webinar. You can access this webinar now along with many others in our library of replays.
In addition to the ARRO del Regato webinars and the research awards, the ROI is currently inviting nominations for its annual Publication Award. This award recognizes the best scientific work in one of the ROI's priority research areas that is authored by an early career professional. The winner will be announced at this year’s ASTRO Annual Meeting, and the recognition includes a $5,000 grant for the lead author to continue the research chosen for the award.
To continue to fulfill its mission, the ROI relies on you for financial support. We encourage you to consider making a monthly gift to the ROI that will help keep essential radiation oncology research moving forward through these challenging times and into the future. You will become a member of the ROI Sustainers’ Circle, and your regular gifts will add up to make a lasting impact on the field. Your support makes it possible for the ROI to continue its efforts in research and education. The ROI is ASTRO’s Research Foundation created to serve you and your patients. Please consider making a generous contribution to the ROI today.
Deborah A. Kuban, MD, FASTRO
Colleen A.F. Lawton, MD, FASTRO
ROI Vice President